PBS Biotech Revenue and Competitors
Estimated Revenue & Valuation
- PBS Biotech's estimated annual revenue is currently $14.7M per year.
- PBS Biotech's estimated revenue per employee is $155,000
- PBS Biotech's total funding is $45M.
Employee Data
- PBS Biotech has 95 Employees.
- PBS Biotech grew their employee count by 25% last year.
PBS Biotech's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | SVP Sales and Marketing | Reveal Email/Phone |
3 | VP Finance & Corporate Controller | Reveal Email/Phone |
4 | Head Engineering | Reveal Email/Phone |
5 | Executive Director, Bioprocess Research & Development | Reveal Email/Phone |
6 | Chief Operating Officer, EVP | Reveal Email/Phone |
7 | Executive Director, Quality | Reveal Email/Phone |
8 | Senior Director, Applications Engineering | Reveal Email/Phone |
9 | Director Information Technology | Reveal Email/Phone |
10 | Director Quality Management | Reveal Email/Phone |
PBS Biotech Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.5M | 27 | -7% | N/A | N/A |
#2 | $4096.4M | 10837 | 2% | N/A | N/A |
What Is PBS Biotech?
PBS Biotech, Inc. in Camarillo, CA designs & manufactures the industry's most advanced single-use bioreactors and disposable vessels and bags. Offering low shear, fast cell culture mixing and ease of scale the PBS product family allows biotech firms worldwide to gain operational efficiencies, cost savings, process flexibility and accelerate time to market in developing monoclonal antibodies (mAbs), proteins (non-mAbs), viruses & vaccines, stem cells, personalized medicine and more including the fast growing biosimilar market. The PBS team of scientists and engineers partners with our customers to provide an optimum and innovative bioprocess solution to their lab through production needs. Employing an easy to use and plug and play configuration, PBS bioreactors are fully scalable from 3 liter to 2500 liter. A patented low-shear Air Wheel(tm) mixing mechanism and intuitive touch screen operation provide maximum efficiency with minimum space requirements for a wide range of biotech processes from lab to cGMP production. Applications & processes with plant, animal and insect cell cultures include viral production, monoclonal antibodies (mAbs), perfusion, transient transfection, stem cells and personalized medicine. The PBS family of single-use bioreactors are designed by scientists for scientists. www.pbsbiotech.com Contact us: info@pbsbiotech.com
keywords:N/A
$45M
Total Funding
95
Number of Employees
$14.7M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
PBS Biotech News
... Getinge AB, Merck KGaA, PALL CORPORATION (DANAHER CORPORATION), Eppendorf AG, Bioengineering, Cellexus, PBS Biotech Inc., Distek Inc.
Solaris Biotechnology s.r.l, Danaher Corporation, Finesse Solutions Applikon Biotechnology B.V., PBS Biotech Sartorius AG, Eppendorf AG, ZETA Holding GmbH, GE...
source: PBS Biotech webiste PBS Biotech, a Camarillo, CA-based single-use bioreactor manufacturer, closed a $10M funding round. BroadOak Capital Partners made the investment. The company intends to use the funds to expand and industrialize its portfolio of single-use bioreactor systems and co ...
Single-use bioreactor manufacturer, PBS Biotech, recently closed a private $10M funding round with BroadOak Capital Partners. The financing will enable the company to expand and industrialize its portfolio of single-use bioreactor systems and contract process development services. “Cell therapi ...
Other Companies in Camarillo
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $33.5M | 95 | 6% | N/A |
#2 | $23.6M | 96 | 8% | N/A |
#3 | $33.9M | 96 | 25% | N/A |
#4 | $14.4M | 99 | N/A | N/A |
#5 | $25.5M | 104 | 7% | N/A |